Skip to content

Celecoxib D7

Celecoxib D7

Product Description
CAT No.
ALN-C005D02
CAS No.
544686-21-7
Mol. F.
C17H7D7F3N3O2S
Mol. Wt.
388.4
Stock
Please Inquire
Chemical Name : 4-(5-(4-(Methyl-d3)phenyl-2,3,5,6-d4)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
Smiles : FC(F)(C1=NN(C2=CC=C([S](N)(=O)=O)C=C2)C(C(C([2H])=C3[2H])=C(C([2H])=C3C([2H])([2H])[2H])[2H])=C1)F
Inchi : InChI=1S/C17H14F3N3O2S/c1-11-2-4-12(5-3-11)15-10-16(17(18,19)20)22-23(15)13-6-8-14(9-7-13)26(21,24)25/h2-10H,1H3,(H2,21,24,25)/i6D,7D,8D,9D

Development of a Unified Reversed-Phase HPLC Method for Efficient Determination of EP and USP Process-Related Impurities in Celecoxib Using Analytical Quality by Design Principles

Tim Tome, Zdenko u010casar ,OrcID andAleu0161 ObrezanMolecules 2020, 25(4), 809

A selective and sensitive LC-MS/MS method for the simultaneous determination of twopotential genotoxic impurities in celecoxib

Ambavaram Vijaya Bhaskar Reddy, Nandigam Venugopal & Gajulapalle Madhavi – Journal of Analytical Science and Technology volume 5, Article number: 18 (2014)

Stability-Indicating HPLC Method for Quantification of Celecoxib and Diacerein Along With Its Impurities in Capsule Dosage Form

Hanimi Reddy Bapatu, Ravi Kumar Maram, R. Satyanarayana Murthy – Journal of Chromatographic Science, Volume 53, Issue 1, January 2015, Pages 144–153

Request For Quotation